HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Nonmedical use of prescription and nonprescription drugs is a worldwide epidemic, rapidly
growing in magnitude with deaths because of overdose and chronic use. A vast majority of …

Cardiovascular toxicity of contemporary antiretroviral thera... : Current Opinion in HIV and AIDS
Cardiovascular toxicity of contemporary antiretroviral therapy : Current Opinion in HIV and …

Although the extensive rollout of antiretroviral (ARV) therapy resulted in a longer life
expectancy for people living with human immunodeficiency virus (PLHIV), such individuals …

Contemporary World Health Organization data indicates that≈ 39 million people are living
with the human immunodeficiency virus. Of these, 24 million have been reported to have …

Aims The extent to which human immunodeficiency viral (HIV) infection is independently
associated with myocardial disease in the era of combination antiretroviral therapy (cART) …

Although the underlying mechanisms driving human immunodeficiency virus (HIV)-mediated
cardiovascular diseases (CVD) onset and progression remain unclear, the role of chronic …

Background: People living with human immunodeficiency virus (HIV+) have greater risk for
sudden arrhythmic death than HIV-uninfected (HIV–) individuals. HIV-associated abnormal …

Background People living with HIV have higher sudden cardiac death (SCD) rates
compared with the general population. Whether HIV infection is an independent SCD risk …

In the United States,> 1 million people are living with HIV, and% 50% are> 50 years old. 1
Potent combination antiretroviral therapy (ART) has significantly reduced the morbidity and …